Izotropic
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
800 24 Ave Suite 424, Surrey, British Co...Phone Number
(778) 228-2314Website
www.izocorp.comRevenue
<$5 MillionStock Symbol
1R3.FIndustry
About Izotropic
Izotropic Corporation specializes in breast CT imaging with its innovative IzoView 3D system, designed to provide high-resolution imaging without compression, enhancing accuracy and comfort for breast cancer detection. The IzoView platform specifically targets the 50% of women with dense breast tissue, where traditional imaging methods often fall short. With a focus on advancing breast cancer imaging technology, Izotropic is preparing for pivotal clinical studies to establish its leadership in this emerging market. The company is driven by a multidisciplinary team of experts and aims to capitalize on the growing demand for earlier and more accurate cancer detection.Explore more
Izotropic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Izotropic
Compare insights from companies similar to Izotropic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Izotropic Tech Stack
A closer look at the technologies used by Izotropic
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Izotropic
Sign Up For FreeTo access detailed company insights
Izotropic Corporation specializes in breast CT imaging with its innovative IzoView 3D system, designed to provide high-resolution imaging without compression, enhancing accuracy and comfort for breast cancer detection. The IzoView platform specifically targets the 50% of women with dense breast tissue, where traditional imaging methods often fall s... Read More
